These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4132609)

  • 21. Australia antigen survey in Hungary. 3. Morphological study of the antigen before and after treatment with Tween 80.
    Hollós I; Neumark T; Novák E; Szécsey G; Penke Z; Köszeghy Z; Villányi P
    Acta Microbiol Acad Sci Hung; 1973 Feb; 20(2):89-101. PubMed ID: 4130012
    [No Abstract]   [Full Text] [Related]  

  • 22. [Australia antigen and the agents of hepatitis. Serologic methods for detection and electron microscopy].
    German A; Couleru O; Panouse-Perrin J; Peter F
    Prog Immunobiol Stand; 1971; 5():55-62. PubMed ID: 4144998
    [No Abstract]   [Full Text] [Related]  

  • 23. Preparation of a dane core (hepatitis B) antigen from human plasma.
    Fauvel M; Babiuk L; Sheaff ET; Spence L
    Can J Microbiol; 1975 Jun; 21(6):905-10. PubMed ID: 1097073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Australia antigen in children suffering from viral hepatitis.
    Dobrzyński L; Oziemska-Lozińska H; Madaliński K
    Acta Virol; 1973 Jan; 17(1):90-3. PubMed ID: 4405401
    [No Abstract]   [Full Text] [Related]  

  • 25. Visualization of virus-like particles in endoplasmic reticulum of hepatocytes of Australia antigen carriers.
    Stein O; Fainaru M; Stein Y
    Lab Invest; 1972 Mar; 26(3):262-9. PubMed ID: 5016045
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum "virus-like" particles in chronic hepatitis and cirrhosis: relation to immunological tests for hepatitis B antigen.
    Jokelainen PT; Krohn K; Finlayson ND; Prince AM
    Gastroenterology; 1973 Nov; 65(5):796-801. PubMed ID: 4758976
    [No Abstract]   [Full Text] [Related]  

  • 27. Electron microscopy of coronavirus-like particles characteristic of turkey bluecomb disease.
    Ritchie AE; Deshmukh DR; Larsen CT; Pomeroy BS
    Avian Dis; 1973; 17(3):546-58. PubMed ID: 4748343
    [No Abstract]   [Full Text] [Related]  

  • 28. [Australia-(hepatitis-B-) antigen. Properties and clinical significance].
    Sauerbruch T
    Med Klin; 1974 Dec; 69(51-52):2106-15. PubMed ID: 4216755
    [No Abstract]   [Full Text] [Related]  

  • 29. Alteration of hepatitis B antigen (HB Ag) determinants by reduction and alkylation.
    Dreesman GR; Hollinger FB; McCombs RM; Melnick JL
    J Gen Virol; 1973 Apr; 19(1):129-34. PubMed ID: 4130961
    [No Abstract]   [Full Text] [Related]  

  • 30. The Australia antigen in viral hepatitis: a changing concept.
    Galambos JT
    J La State Med Soc; 1971 Aug; 123(8):277-81. PubMed ID: 4998038
    [No Abstract]   [Full Text] [Related]  

  • 31. A simple procedure for purification of hepatitis B-antigen.
    Cruceanu A; Müller R; Deicher H
    Med Microbiol Immunol; 1973 Sep; 159(1):83-8. PubMed ID: 4769894
    [No Abstract]   [Full Text] [Related]  

  • 32. A study of the relationship of virus-like particles and Australia antigen in liver.
    Huang SN; Groh V; Beaudoin JG; Dauphinee WD; Guttmann RD; Morehouse DD; Aronoff A; Gault H
    Hum Pathol; 1974 Mar; 5(2):209-22. PubMed ID: 4359686
    [No Abstract]   [Full Text] [Related]  

  • 33. [Purification of the Australia antigen by molecular sieving and affinity chromatography (author's transl)].
    Cherchel GL; Valet JP; Matte J; Ackerman HW
    Nouv Rev Fr Hematol; 1974; 14(3):341-54. PubMed ID: 4277913
    [No Abstract]   [Full Text] [Related]  

  • 34. Full and empty particles of hepatitis B virus in hepatocytes from patients with HBsAg-positive chronic active hepatitis.
    Sakamoto Y; Yamada G; Mizuno M; Nishihara T; Kinoyama S; Kobayashi T; Takahashi T; Nagashima H
    Lab Invest; 1983 Jun; 48(6):678-82. PubMed ID: 6855194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Physico-chemical properties of purified Australia antigen].
    Peyron L; Ruel JP; Tayot JL; Roumiantzeff M
    Prog Immunobiol Stand; 1971; 5():8-15. PubMed ID: 4633983
    [No Abstract]   [Full Text] [Related]  

  • 36. Considerations on several methods for the purification of viral hepatitis antigen (HB Ag).
    Cruceanu A; Repanovici R; Babeş VT; Müller R; Deicher H
    Rev Roum Virol (1972); 1974; 11(2):127-31. PubMed ID: 4601232
    [No Abstract]   [Full Text] [Related]  

  • 37. Infectious nucleocapsid particles of lettuce necrotic yellows virus with RNA-dependent RNA polymerase activity.
    Randles JW; Francki RI
    Virology; 1972 Oct; 50(1):297-300. PubMed ID: 4117126
    [No Abstract]   [Full Text] [Related]  

  • 38. Biophysical properties of coronavirus strain OC 43.
    Pokorný J; Brůcková M; Rýc M
    Acta Virol; 1975 Apr; 19(2):137-42. PubMed ID: 239559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Peculiar aspects of viral type particles ("viroplasms") in hepatocytes in hepatitis with Australia antigen].
    Leung TK; Feroldi J; Bertrand ; Bonnamour C; Brette R
    Ann Anat Pathol (Paris); 1975; 20(3):293-302. PubMed ID: 1211676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of cores from hepatitis B Dane particles.
    Lipman MB; Hierholzer WJ; Schluederberg A
    J Infect Dis; 1973 Nov; 128(5):664-7. PubMed ID: 4203530
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.